Mirati Therapeutics Stock Price

7.98 (4.72%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mirati Therapeutics Inc MRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
7.98 4.72% 177.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
170.24 162.89 174.97 174.05 169.02
Bid Price Ask Price Spread News
142.25 210.00 67.75 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,079 950,956 $ 167.04 $ 158,848,993 - 131.465 - 249.42
Last Trade Time Type Quantity Stock Price Currency
19:18:20 19 $ 197.98 USD


Draw Mode:

Mirati Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.14B 51.62M 40.81M $ 13.40M $ - -7.96 -16.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -40.00k 0.90%

more financials information »

Mirati Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week167.83174.97159.525166.62398,7119.175.46%
1 Month132.14176.73132.14163.46384,03544.8633.95%
3 Months164.48176.73131.465160.92452,58712.527.61%
6 Months188.40189.74131.465160.93484,957-11.40-6.05%
1 Year159.39249.42131.465182.31474,63417.6111.05%
3 Years55.20249.4228.50110.49556,099121.80220.65%
5 Years5.02249.422.7079.37514,817171.983,425.9%

Mirati Therapeutics Description

Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.

Your Recent History
Mirati The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.